A Randomized, Double Blind, Placebo Controlled, Flexible Dose, Multicentre Study of Levitra [Vardenafil, BAY38-9456] in a Broad Population of Men With Erectile Dysfunction and Previously Untreated With PDE5 Inhibitors
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2015
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms FINDER
- Sponsors Bayer
- 01 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004035).
- 18 Nov 2009 Additional trial location (Spain) identified as reported by ClinicalTrials.gov.
- 16 May 2008 New trial record.